State of the Art Lectures

Date: Saturday 19 October 2019
Time: 15:30-18:30
Chairs: Chrystelle Colas (France), Aung Ko Win (Australia)

Time Session
15:30 – 15:50 The Manchester consensus for gynecologic risk in Lynch syndrome – Neil Ryan (UK)
15:50 – 16:10 Path_MSH6 carriers: identification and clinical implications – Heather Hampel (USA)
16:10 – 16:30 The identification and characterization of PMS2-carriers: an epidemiological and molecular approach – Mev Dominguez-Valentin (Norway), Sanne ten Broeke (The Netherlands)
16:30 – 16:50 MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of coloncancer  – Giulia Martina Cavestro (Italy)
16:50 – 17:10 Aggressive cases of MSH6 and PMS4 and clinical implications – Michael Hall (UK)
17:10 – 17:30 Panel testing for inherited cancer genes: which genes when? – Gabriel Capella (Spain)
17:30 – 17:50 Polygenic Risk Scores – Jack Cuzick (UK)
17:50 – 18:10  How to assess cost/efficacy of alternative models for preventing / curing CRC – Yoon-Jung Kang (Australia)
18:10 – 18:30 Cancer prevention in Lynch syndrome: news from vaccination studies – Magnus von Knebel-Doeberitz (Germany)
Adjourn and next meeting announcement
Top